Publications

Topics
  • high value care
    September 20th, 2023
    https://cdn.regencehpc.com
    high value care
    September 20th, 2023

    Oregon brings together hospitals and health insurers to discuss health care cost growth trends

    This month, Oregon held a public hearing to hear perspectives from hospitals and health insurers, including Regence BlueCross BlueShield of Oregon, about health care cost growth trends and strategies to address them.
    https://cdn.regencehpc.com
    Julie Schultz
    2 min read
  • September 7th, 2023
    https://cdn.regencehpc.com
    September 7th, 2023

    Summer Conference Recap: Behavioral health access & curbing health care costs

    Regence Health Policy Center staff participated in two influential conferences aimed at developing policy solutions to expand access to behavioral health services and curb the affordability crisis.
    https://cdn.regencehpc.com
    Nolan Jekich
    min read
  • prescription drugs
    December 1st, 2022
    prescription drugs
    December 1st, 2022

    Improving Drug Affordability: The Promise of Biosimilars

    Biosimilars were first approved for use in the United States in 2015. With a growing number of available biosimilar products and a need to decrease the costs associated with prescription drugs, are biosimilars on track to deliver the savings promised? What role do payers and providers play in advancing broader adoption of biosimilars as a safe and effective treatment? Read key takeaways from the virtual discussion and view the recording!
    https://cdn.regencehpc.com
    Laura Sconyers
    2 min read
  • prescription drugs
    November 18th, 2022
    https://cdn.regencehpc.com
    prescription drugs
    November 18th, 2022

    Regence Leads the Industry in Biosimilar Adoption

    Greater adoption of biosimilars is one path to driving down drug costs in the United States. Effectively increasing uptake will require collaboration between all segments of the health care system. Regence health plans are leading the industry in biosimilars utilization with 95 percent adoption, thus reducing specialty drug spend by $30 million since 2019.
    https://cdn.regencehpc.com
    Laura Sconyers
    4 min read
  • prescription drugs
    November 10th, 2022
    https://cdn.regencehpc.com
    prescription drugs
    November 10th, 2022

    What’s in the Bag? Revealing hospitals' excessive markups on specialty drugs

    With the cost of prescription drugs on the rise, specialty drugs that treat the most severe conditions and illnesses are no exception. We explore the importance of cost control strategies to acquire specialty drugs and how some health care providers are aiming to remove these strategies to increase their revenue margins.
    https://cdn.regencehpc.com
    https://cdn.regencehpc.com
    Nolan Jekich,
    Adam Furman
    8 min read
  • October 27th, 2022
    https://cdn.regencehpc.com
    October 27th, 2022

    2022 Oregon State of Reform Health Policy Conference

    The RHPC team sponsored and attended the 2022 Oregon State of Reform Health Policy Conference, bringing together stakeholders from across the region to discuss the most important topics facing the state.
    https://cdn.regencehpc.com
    Laura Sconyers
    4 min read
  • prescription drugs
    October 26th, 2022
    https://cdn.regencehpc.com
    prescription drugs
    October 26th, 2022

    Drug Manufacturers’ Billion-Dollar Scheme

    Copay coupons—the solution for the unreasonable cost of specialty medications or a carefully crafted trojan horse disrupting affordability in our health care system?
    https://cdn.regencehpc.com
    Julie Onizuka
    7 min read
  • prescription drugs
    October 12th, 2022
    https://cdn.regencehpc.com
    prescription drugs
    October 12th, 2022

    Oregon Attempts to Address the High Costs of Drugs: Q&A with DCBS Director Andrew Stolfi

    In 2018, Oregon passed a law creating the Oregon Prescription Drug Price Transparency program. The program has been able to provide policymakers, consumers and stakeholders across healthcare with information about the one of the most complicated areas in health care- pharmaceuticals. We spoke with Oregon DCBS Director, Andrew Stolfi, to discuss the Prescription Drug Price Transparency Program and the newly created Prescription Drug Affordability Board.
    https://cdn.regencehpc.com
    https://cdn.regencehpc.com
    Vince Porter,
    Andrew Stolfi
    6 min read
  • prescription drugs
    October 5th, 2022
    https://cdn.regencehpc.com
    prescription drugs
    October 5th, 2022

    Prescription Drug Costs: Striking a Balance Between Innovation and Affordability

    We are living in a new “golden age” of prescription drug innovation. Over the last several years, advancements in biologics, as well as the development of cell and gene therapies offer tremendous promise for extending people’s quality of life and even curing debilitating diseases. The downside is that these are among the most expensive drug therapies on the market with more to come.
    https://cdn.regencehpc.com
    Jack Quinn
    3 min read

Subscribe to our newsletter

Our newsletter keeps you informed with all the Regence Health Policy Center's programming, initiatives and community events.